v3.25.4
Stockholders' Equity (Tables)
 12 Months Ended
Dec. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Summary of RSU and RSA Award Activity
The following table summarizes the RSU and RSA activity for the year ended December 31, 2025:
Number of
Class A Shares		Weighted-
Average
Grant Date
Fair Value
(in thousands, except per share data)
Unvested as of December 31, 2024134,253$11.90 
Granted175,226$8.51 
Vested(107,610)$10.89 
Forfeited(34,495)$10.79 
Unvested as of December 31, 2025167,374$9.23 
Summary of Stock Option Award Activity
The following table summarizes the stock option award activity under the 2017 Plan for the year ended December 31, 2025:
Number of
Class A Shares		Weighted-
Average
Exercise
Price		Weighted-
Average
Remaining
Contractual
Term
(in years)
Aggregate Intrinsic Value (1)
(in thousands, except per share and year data)
Outstanding as of December 31, 2024680$16.01 4.51$253 
Granted—$— —$— 
Exercised(58)$6.43 —$— 
Forfeited(103)$12.56 —$— 
Outstanding as of December 31, 2025519$17.77 3.74$— 
Exercisable as of December 31, 2025519$17.77 3.74$— 
Vested and expected to vest as of December 31, 2025519$17.77 3.74$— 
(1)The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying stock option awards and the closing market price of our Class A common stock as of December 31, 2025 and December 31, 2024.
Summary of Total Stock-based Compensation Expense
Total stock-based compensation expense by function was as follows:
Year Ended December 31,
202520242023
(in thousands)
Cost of revenue$7,426 $6,034 $9,555 
Research and development680,602 683,830 893,026 
Sales and marketing198,013 216,672 255,688 
General and administrative130,784 134,487 165,735 
Total$1,016,825 $1,041,023 $1,324,004